CAI

Caris Life Sciences, Inc.

• PR Newswire·17h ago

  Caris Life Sciences Launches Behind the Diagnosis Campaign Spotlighting Patient Lives Transformed by Caris' Comprehensive Genomic Testing

• PUBT·4d ago

  Caris studies MSH3 loss impact on immune checkpoint outcomes across cancers at ASCO 2026

• Benzinga·05/18 14:12

  Stanley Druckenmiller Dumps Amazon And Alphabet While Loading Up On Commodities, Argentina And Biotech

• Barron‘s·05/15 21:59

  Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying.

• Seeking Alpha·05/15 20:48

  Stanley Druckenmiller's Duquesne initiates stake in AVGO, dumps GOOGL among Q1 moves

• Benzinga·05/15 12:36

  Caris Life Sciences Announces Publication Of A Caris‑Led Study In The Oncologist The Shows Its Lookback Program's Ability To Identify Previously-Profiled Patients Who Become Eligible For Newly Approved Targeted Therapies

• Simply Wall St·05/14 17:59

  A Look At Caris Life Sciences (CAI) Valuation After Recent Growth, Product Launches And Clinical Data Advances

• TipRanks·05/14 08:20

  Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Caris Life Sciences, Inc. (CAI)

• TipRanks·05/13 02:12

  Caris Life Sciences Director Makes Bold Insider Move With Major Stock Purchase

• PUBT·05/12 12:23

  Caris director Jeff L Vacirca acquires 31,050 shares for $501,426.95

• TipRanks·05/12 11:31

  Caris Life Sciences, Inc. (CAI) Gets a Hold from Piper Sandler

• TipRanks·05/12 06:22

  Analysts Are Bullish on Top Healthcare Stocks: Genmab (GMAB), Caris Life Sciences, Inc. (CAI)

• TipRanks·05/11 17:55

  Caris Life Sciences announces publication of study on measuring TMB using WES

• PUBT·05/11 16:15

  Caris study finds whole exome TMB predicts pembrolizumab survival better than gene panels

• PR Newswire·05/11 16:15

  Caris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels